Immunological response in HIV-associated tuberculosis and the implications of HIV in the search for a tuberculosis vaccine

D. Goletti (Rome, Italy)

Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?

Session: Tuberculosis control and HIV in Europe: good or bad news?
Session type: Symposium
Number: 364

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Goletti (Rome, Italy). Immunological response in HIV-associated tuberculosis and the implications of HIV in the search for a tuberculosis vaccine. Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005
Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience Source: Eur Respir J 2016; 47: 333-336 Year: 2016
The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis Source: Eur Respir J 2016; 48: 963-971 Year: 2016
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001
Epidemiological features of nosocomial tuberculosis in patients with pulmonary tuberculosis in TB hospital Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018
Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence Source: Milan 2017 - Educational material Year: 2017
MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020
Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009
Long-term treatment outcomes in multidrug-resistant tuberculosis (MDR-TB) Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis Year: 2007
Evaluation of treatment outcomes for multidrug-resistant tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001
Multidrug-resistant tuberculosis in UK children: presentation, management and outcome Source: Eur Respir J 2013; 41: 1456-1458 Year: 2013
Clinical and operational value of the extensively drug-resistant tuberculosis definition Source: Eur Respir J 2007; 30: 623-626 Year: 2007
The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Clinical, epidemiologic and social peculiarities of XDR pulmonary tuberculosis (PTB) patients Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011
Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Psychiatric issues during the treatment of the patients with multidrug-resistant tuberculosis Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005